Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 21.18% vs -12.92% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 30.87% vs 38.95% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 2.77% vs -5.88% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 11.11% vs 16.13% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Apeloa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 21.18% vs -12.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.98% vs -14.99% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 30.87% vs 38.95% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.28% vs 2.01% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 2.77% vs -5.88% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -17.21% vs -8.68% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 11.11% vs 16.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 70.21% vs -44.05% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






